Godlike Productions - Reply to Thread

Users Online Now: 2,979 (Who's On?)	Visitors Today: 1,452,866
Pageviews Today: 2,612,940	Threads Today: 1,103	Posts Today: 19,263
10:07 PM

Back to Thread

REPLY TO THREAD

Subject <<Advancing Bird Flu-H5N1...now its Vietnam and spreading?

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

[quote:arkay:MV8xNzc2Mjk3XzM0NzAzNTMxXzEwMjI3MTcx]
This next article reports on an American study undertaken on reports of Guillain-Barré syndrome (GBS) developing after vaccinations.

In the conclusions it clearly states.."Although the nonnormal distribution of post-vaccination GBS suggests that some cases may be triggered by vaccination".

But then goes on to RECOMMEND first line protection remains vaccination!

I cannot believe that these people would make such a recommendation in light of the results of their studies.

And another thing too.

Did their study look at the cumulative affects of regular annual vaccinations, they should have as mercury to name one common ingredient accumulates in the human body, so the TOTAL number of vaccinations over an entire life must be taken into account for the study to be meaningful.

This might be an over simplistic view, but are these people doing this work actually totally independant, or is there some awareness or presence of big pharmacy somewhere in this picture that isnt being made known?

[i][b]J Clin Neuromuscul Dis. 2012 Dec;14(2):66-71. doi: 10.1097/CND.0b013e31824db14e.
Guillain-Barré Syndrome After Influenza Vaccination in the United States, A Report From the CDC/FDA Vaccine Adverse Event Reporting System (1990-2009).
Souayah N, Yacoub HA, Khan HM, Farhad K, Mehyar LS, Maybodi L, Menkes DL, Qureshi AI.
Source*Department of Neurology, University of Medicine and Dentistry of New Jersey, Newark, NJ †Department of Biostatistics, Robert Stempel College of Public Health & Social Work, Florida International University, Miami, FL ‡Department of Neurology, University of Connecticut Health Center, Farmington, CT §Zeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis, MN.

Abstract
OBJECTIVES: : To determine the rate of Guillain-Barré syndrome (GBS) after administration of influenza vaccine in the United States and to provide further information about the characteristics and temporal profile of these incidents.

METHODS: : Data were acquired from the Vaccine Adverse Event Reporting System, supplemented by data from the Center for Biologics and Research under the Freedom of Information Act between 1990 and 2009.

RESULTS: : There were 802 cases (mean age, 54.72 ± 18.4 years) of GBS reported after influenza vaccination in the United States between 1990 and 2009. Among the 802 vaccinated patients with available data, 624 (77.8%) developed GBS within 6 weeks and 78 (9.7%) after 6 weeks, whereas these data were unavailable for the remaining 100 patients (13%). The reporting rate of post-influenza vaccine GBS was within the range expected in the general population or approximately 0.46 cases per million vaccinations. A non-Gaussian distribution of GBS within the first 6 weeks post-vaccination was noted, given that the peak incidence occurred in the second week.

CONCLUSIONS: : The incidence of post-influenza vaccine GBS is similar to the incidence of idiopathic GBS in the general population. Although the nonnormal distribution of post-vaccination GBS suggests that some cases may be triggered by vaccination, the greater risk of complications from influenza virus infections makes vaccination the first-line strategy for infection prevention and support the current guidelines on vaccination.[/b][/i]

Link here...

http://www.ncbi.nlm.nih.gov/pubmed/23172385
[/quote]

Original Message I previously engaged in several threads regarding the potentially devestating potential of H5N1.

Some readers who havent even attempted to gain any sort of education have downvoted my thread to the point that no-one got the chance to read and learn, on a topic that I have been closely monitoring for several years, ever since the World Health Organization announced their concerns for it to go pandemic.

Now the following link is showing its steady but relentless advance and in all probability its eventual final evolutionary mutation to become an airborne dissease that will readily spread throughout humanity with devistating effects.

link here:

[link to hisz.rsoe.hu]

Pictures (click to insert)

News